A scientific paper arising from Mologic’s collaboration with Prof Molly Stevens’ research group at Imperial College London has been accepted for publication in the prestigious American Chemical Society Nanotechnology journal, ACS Nano.

“Multivalent nanoparticle networks enable point of care detection of human phospholipase-A2 in serum”.

Robert Chapman, Yiyang Lin, Mark Burnapp, Andrew Bentham, David Hillier, Abigail Zabron,, Shahid Khan, Matt Tyreman & Prof. Molly Stevens.

It is based on the >£1million collaborative R&D project, titled New Point of Care Diagnostics for Clinical Enzyme Biomarkers, jointly funded by the UK Technology Strategy Board (Nanoscale technology enabled healthcare: building the supply chain competition).